Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response.
Potter
Catherine
C
Institute of Cellular Medicine, Musculoskeletal Research Group, Newcastle University.
Gibbons
Laura J
LJ
Bowes
John D
JD
Cordell
Heather J
HJ
Hyrich
Kimme
K
Isaacs
John D
JD
Morgan
Ann W
AW
Wilson
Anthony G
AG
Barton
Anne
A
D051722:ADAM Proteins / Q000235:genetics*; D000072198:ADAM17 Protein; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000235:genetics*; D002874:Chromosome Mapping; D015331:Cohort Studies; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D008957:Models, Genetic; D015999:Multivariate Analysis; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000235:genetics*; D012044:Regression Analysis; D015203:Reproducibility of Results; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D047889:Receptors, Tumor Necrosis Factor, Type II; D014409:Tumor Necrosis Factor-alpha; D051722:ADAM Proteins; D000072198:ADAM17 Protein; C000606462:ADAM17 protein, human